Publication date: Sep 30, 2024
Recent advances in measurement technologies, particularly single-cell RNA sequencing (scRNA-seq), have revolutionized our ability to acquire large amounts of omics-level data on cellular states. As measurement techniques evolve, there has been an increasing need for data analysis methodologies, especially those focused on cell-type identification and inference of gene regulatory networks (GRNs). We have developed a new method named BootCellNet, which employs smoothing and resampling to infer GRNs. Using the inferred GRNs, BootCellNet further infers the minimum dominating set (MDS), a set of genes that determines the dynamics of the entire network. We have demonstrated that BootCellNet robustly infers GRNs and their MDSs from scRNA-seq data and facilitates unsupervised identification of cell clusters using scRNA-seq datasets of peripheral blood mononuclear cells and hematopoiesis. It has also identified COVID-19 patient-specific cells and their potential regulatory transcription factors. BootCellNet not only identifies cell types in an unsupervised and explainable way but also provides insights into the characteristics of identified cell types through the inference of GRNs and MDS.
Open Access PDF
Concepts | Keywords |
---|---|
Bootcellnet | |
Cellular | |
Covid | |
Hematopoiesis | |
Resampling |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | cell |
disease | IDO | blood |
disease | MESH | COVID-19 |
drug | DRUGBANK | Isoxaflutole |
disease | MESH | uncertainty |
disease | IDO | history |
disease | IDO | process |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Coenzyme M |
disease | MESH | boils |
disease | MESH | cancer |
drug | DRUGBANK | Huperzine B |
drug | DRUGBANK | Potassium |
drug | DRUGBANK | Cycloserine |
drug | DRUGBANK | Hyaluronic acid |
disease | IDO | algorithm |
drug | DRUGBANK | Piroxicam |
disease | MESH | inflammation |
disease | MESH | cytokine storms |
drug | DRUGBANK | Methylergometrine |